Syndrome diagnosis with single-nucleotide polymorphism (SNP) microarray

Matthew Edwards, Sally Brescianini, Catherine Allgood, Michael Freelander, Richard Dunstan, Patrick Patradoon-Ho, Raymond Chin, Lucy Morgan, Tasnuba Pervez, Marie Legendre, Trent Burgess, Serge Amselem, John Whitehall

Research output: Contribution to journalArticlepeer-review

Abstract

Conventional G-banded karyotypes diagnose about 3% of children who have intellectual disability with or without congenital abnormalities. Fragile X DNA testing diagnoses a further 1%. Karyotypes detect alterations of the number, shape or size of chromosomes of cultured cells by studying them with a microscope. As the cells have to be cultured in the laboratory there is the chance the diagnosis could be influenced by a culture artefact which either removes an abnormal cell population present in the patient, or introduces a new population not present in the patient. For microarray analysis the patient’s DNA is extracted from blood or other tissue without the need for culture of the cells, removing the risk of culture artefact. Chromosomal microarray tests increase the diagnostic rate in developmental disability by about 13%1 and are now first line tests.
Original languageEnglish
Pages (from-to)85-89
Number of pages5
JournalJournal of Paediatrics and Child Health
Volume52
Issue number1
DOIs
Publication statusPublished - 2016

Keywords

  • chromosomal microarray
  • disabilities
  • genetics
  • pediatrics

Fingerprint

Dive into the research topics of 'Syndrome diagnosis with single-nucleotide polymorphism (SNP) microarray'. Together they form a unique fingerprint.

Cite this